These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263 [TBL] [Abstract][Full Text] [Related]
9. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L. Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment. Tenedini E; Roncaglia E; Ferrari F; Orlandi C; Bianchi E; Bicciato S; Tagliafico E; Ferrari S Cell Death Dis; 2010; 1(2):e28. PubMed ID: 21364636 [TBL] [Abstract][Full Text] [Related]
13. FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis. Desterke C; Bilhou-Nabéra C; Guerton B; Martinaud C; Tonetti C; Clay D; Guglielmelli P; Vannucchi A; Bordessoule D; Hasselbalch H; Dupriez B; Benzoubir N; Bourgeade MF; Pierre-Louis O; Lazar V; Vainchenker W; Bennaceur-Griscelli A; Gisslinger H; Giraudier S; Le Bousse-Kerdilès MC; ; ; Cancer Res; 2011 Apr; 71(8):2901-15. PubMed ID: 21487043 [TBL] [Abstract][Full Text] [Related]
14. A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells. Calura E; Pizzini S; Bisognin A; Coppe A; Sales G; Gaffo E; Fanelli T; Mannarelli C; Zini R; Norfo R; Pennucci V; Manfredini R; Romualdi C; Guglielmelli P; Vannucchi AM; Bortoluzzi S Blood Cancer J; 2016 Jun; 6(6):e439. PubMed ID: 27341078 [TBL] [Abstract][Full Text] [Related]
15. Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis. Abbonante V; Karkempetzaki AI; Leon C; Krishnan A; Huang N; Di Buduo CA; Cattaneo D; Ward CM; Matsuura S; Guinard I; Weber J; De Acutis A; Vozzi G; Iurlo A; Ravid K; Balduini A Am J Hematol; 2024 Mar; 99(3):336-349. PubMed ID: 38165047 [TBL] [Abstract][Full Text] [Related]
16. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Bissels U; Wild S; Tomiuk S; Hafner M; Scheel H; Mihailovic A; Choi YH; Tuschl T; Bosio A Stem Cells; 2011 May; 29(5):847-57. PubMed ID: 21394831 [TBL] [Abstract][Full Text] [Related]
17. [Pathogenic role of insufficiency of polycomb repressive complex in primary myelofibrosis]. Shinoda D Rinsho Ketsueki; 2023; 64(9):998-1006. PubMed ID: 37793876 [TBL] [Abstract][Full Text] [Related]
18. Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis. Chaligné R; James C; Tonetti C; Besancenot R; Le Couédic JP; Fava F; Mazurier F; Godin I; Maloum K; Larbret F; Lécluse Y; Vainchenker W; Giraudier S Blood; 2007 Nov; 110(10):3735-43. PubMed ID: 17709604 [TBL] [Abstract][Full Text] [Related]
19. Immunoproteasome Genes Are Modulated in CD34 Di Rosa M; Giallongo C; Romano A; Tibullo D; Li Volti G; Musumeci G; Barbagallo I; Imbesi R; Castrogiovanni P; Palumbo GA Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331228 [TBL] [Abstract][Full Text] [Related]